Skip to main content


Continuing Education (CME)

6th Biennial Pediatric Neuro-Oncology Research Conference

June 10-12, 2021

This activity is jointly provided by Global Education Group and the Society for Neuro-Oncology 

Target Audience

The educational design of this activity addresses the needs of neuro-oncologists, neurosurgeons, pathologists, scientists, allied health professionals involved in the treatment of pediatric patients with brain tumors.

Statement of Need/Program Overview
The Society for Neuro-Oncology’s 6th Biennial Pediatric Neuro-Oncology Research Conference brings together outstanding leaders in the field of Pediatric Neuro-Oncology and research. Building on the success of our previous pediatric meetings, this biennial conference encourages the sharing of ideas and results, new collaborations, and offers attendees a state-of-the-art update in the field of pediatric brain tumor research. The meeting fosters opportunities to explore collaborations that will positively influence outcomes of Pediatric brain tumor patients. This meeting will be a collaboration of researchers and clinicians disseminating new knowledge to healthcare professionals in order to provide the highest quality of patient care to improve patient outcomes. The goal is to provide healthcare professionals with updated viewpoints, strategies, collaboration opportunities and an increased knowledge base to maximize treatment and management of Pediatric brain tumor patients. 

This year’s meeting will highlight advances in the field of Pediatric Neuro-Oncology from leading Keynote and plenary speakers. The pillars of the meeting will be innovations in the new WHO classifications and development of CAR T cells immunotherapies. 

The purpose of this conference is to provide those interested in the treatment and research of Pediatric patients with updated viewpoints and treatment strategies. Viewpoints and treatment strategies include WHO classifications, immunotherapy and developmental pathways to tumorigenesis. 

Educational Objectives
After completing this activity, the participant should be better able to:

  • Recognize the challenges in the treatment of low-grade gliomas as it relates to the unique characteristics of the brain tumor microenvironment.
  • Recognize new WHO classifications for pediatric CNS tumors and manage patient care accordingly.
  • Indicate how to incorporate CAR T cell immunotherapy in pediatric patient treatment plans.
  • Identify new delivery options to effectively treat brain tumors protected by the blood brain barrier. 

Please click here for the list of Invited Speakers.
Please click here for the list of Keynote Speakers.

Program Agenda
Click here to view current program*.  

*Please note: All educational presentations on June 10th and June 11th are a CME activity. All presentations on June 12th are a non-CME activity.

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and the Society for Neuro-Oncology. Global is accredited by the ACCME to provide continuing medical education for physicians. 

* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation
Global Education Group designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].

Instructions to Receive Credit
In order to receive credit for this activity, the participant must attend the virtual sessions and complete the program evaluation. An individualized CME/CE evaluation link was emailed to each participant on Tuesday, June 15, 2021 from "[email protected]" with the subject line "WebSurvey link."

Deadline to claim CE Credit will be Monday, July 12th at 11:59pm ET.

System Requirements

Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader* 

MAC OS 10.2.8
Flash Player Plugin (v7.0.1.9 or greater)
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh. 
*Required to view printable (PDF) version of the lesson.

Refund/Cancellation Policy
The deadline for cancellations with refund is Monday, May 24, 2021. Cancellations must be received in writing and a $50 cancellation fee will be assessed. Cancellations received after the deadline date cannot be refunded, but the meeting registration can be transferred to another person with written authorization.

Payment must be received in full before access to the virtual meeting can be granted. Please note that your SNO membership must be current if you have chosen to register as a SNO member. SNO reserves the right to confirm that you have registered in the correct category and may cancel your registration if it is determined otherwise. Following the cancelation deadline, SNO will refund registrations that are cancelled for administrative reasons only; for all other registrations, no refunds are possible.

Email all cancellation and transfer requests to Program Registrar Caroline Noor, [email protected].

Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated. 

Please find the disclosures of all individuals in control of content for the program by clicking here.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Society for Neuro-Oncology do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Click here to return to the SNO Pediatric Conference homepage.